The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 03, 2020
Filed:
Jun. 29, 2018
Applicant:
Medtronic, Inc., Minneapolis, MN (US);
Inventors:
Pedram Afshar, San Francisco, CA (US);
Timothy J. Denison, Minneapolis, MN (US);
David E. Linde, Corcoran, MN (US);
Scott R. Stanslaski, Shoreview, MN (US);
Assignee:
Medtronic, Inc., Minneapolis, MN (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/00 (2006.01); A61B 5/04 (2006.01); A61B 5/0478 (2006.01); A61N 1/36 (2006.01); G06F 19/00 (2018.01); G16H 20/40 (2018.01); G16H 50/20 (2018.01); A61N 1/05 (2006.01);
U.S. Cl.
CPC ...
A61B 5/04012 (2013.01); A61B 5/0478 (2013.01); A61B 5/4082 (2013.01); A61B 5/4836 (2013.01); A61B 5/686 (2013.01); A61N 1/36067 (2013.01); A61N 1/36139 (2013.01); A61N 1/36171 (2013.01); G06F 19/00 (2013.01); G06F 19/3481 (2013.01); G16H 20/40 (2018.01); G16H 50/20 (2018.01); A61N 1/0534 (2013.01);
Abstract
The disclosure describes a method and system or controlling symptoms of patients suffering from Parkinson's Disease. In some examples, one or more biomarkers indicative of a patient's present symptoms are determined. The biomarkers may be used to control therapy delivered to the patient in a closed-loop manner. In addition, biomarkers may be used as an indication of therapy effectiveness.